PPARGC1A and ovarian cancer: The upregulation of VDAC1 mediated by the overexpression of PGC1α along with HSP70 was found to result in the increased glycolysis and reduced mitochondrial function in ovarian cancer cells; indicating the potential of VDAC1 as a therapeutic target in ovarian cancer [61].